Seer to Present at the BofA Securities 2021 Healthcare Conference
May 04 2021 - 4:05PM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
be participating virtually in the upcoming BofA Securities 2021
Healthcare Conference.
Seer’s management is scheduled to participate in
a fireside chat on Thursday, May 13 at 10:15 a.m. Pacific Time /
1:15 p.m. Eastern Time. A live webcast of the virtual session will
be available on the Investor section of Seer’s website at
investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About SeerSeer is a life sciences company
developing transformative products that open up a new gateway to
the proteome. Seer is commercializing its Proteograph Product
Suite, an integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy-to-use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
adopted by nearly any lab. Seer’s Proteograph Product Suite is for
research use only and is not intended for diagnostic procedures.
For more information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren
Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024